Related Experiment Video
Updated: Aug 1, 2026

Novel RNA-Binding Proteins Isolation by the RaPID Methodology
Published on: September 30, 2016
Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development
1Département de Biochimie, Université de Montréal, C.P. 6128, succursale Centre-ville, Montréal, Québec, Canada. ibrukner@hotmail.com
Abstract:
There are numerous indications that the "antisense" mechanism alone cannot account for the observed effects in living cells. Despite that, interactions between antisense oligonucleotides (ASO) and cellular proteins are usually not considered. In this work, we have tested the ability of antisense phosphorothioate (SdT) oligonucleotides and natural deoxyoligonucleotides (dT) for their ability to interact with target RNA in the presence of cellular proteins. We show that the affinity for cellular proteins is an essential factor that determines the success of RNA targeting. We have used a simple nuclease digestion assay to detect RNA/ASO hybrid formation in the presence of proteins. The results show the inability of a phosphorothioate oligonucleotide (SdT18) to reach the target RNA (rA18) in vitro in the presence of proteins. However, if proteins are absent, the RNA targeting was successful, as is usual in in vitro assays. Note that the target RNA concentration exceeded physiological values by several orders of magnitude while the crude protein extract was 20-fold diluted in the reaction tube. This finding is compatible with the notion that therapeutic properties of phosphorothioates could largely derive from a so-called "aptamer" effect.
Insights
Cellular proteins hinder antisense oligonucleotides (ASOs) from targeting RNA. This suggests phosphorothioate ASOs may work via an "aptamer" effect, not just antisense mechanisms.
Area of Science:
- Molecular Biology
- Oligonucleotide Therapeutics
Background:
- Antisense oligonucleotides (ASOs) are therapeutic agents targeting RNA.
- The role of cellular protein interactions with ASOs is often overlooked.
- The "antisense" mechanism alone may not fully explain ASO efficacy in cells.
Purpose of the Study:
- To investigate the impact of cellular proteins on the RNA-targeting ability of antisense oligonucleotides.
- To compare the efficacy of phosphorothioate (SdT) and natural deoxyoligonucleotides (dT) in the presence of cellular proteins.
- To explore the potential for an "aptamer" effect in phosphorothioate ASO activity.
Main Methods:
- Utilized a nuclease digestion assay to detect RNA/ASO hybrid formation.
- Tested RNA targeting in the presence and absence of cellular proteins.
- Used phosphorothioate (SdT18) and natural deoxyoligonucleotides (dT18) against a target RNA (rA18).
Main Results:
- Cellular proteins significantly inhibited the ability of phosphorothioate oligonucleotides (SdT18) to form hybrids with target RNA (rA18) in vitro.
- RNA targeting by SdT18 was successful in the absence of proteins, consistent with standard in vitro assays.
- Even with diluted protein extract and high target RNA concentrations, protein presence blocked SdT18 binding.
Conclusions:
- Affinity for cellular proteins is a critical factor influencing the success of RNA targeting by ASOs.
- The observed inhibition by proteins suggests that the therapeutic effects of phosphorothioates might stem from an "aptamer" effect rather than solely the antisense mechanism.
- Further research is needed to elucidate the precise mechanisms of ASO action, considering protein interactions.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Experimental RNAi
Inhibitors of Viral Protein Synthesis

